Apotex Inc. Recall: Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 5
Apotex Inc. Recall: Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 5 is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Apotex Inc.; Product: Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 500 count bottle, Rx Only, Manufactured by: Apotex Resea
| Recalling firm | Apotex Inc. |
|---|---|
| Product | Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 500 count bottle, Rx Only, Manufactured by: Apotex Research Pvt., Ltd., Bangalore, India, Manufactured for: Apotex Corp, Westin, FL, a) NDC 60505-3145-1, b) NDC 60505-3145-5 |
| Reason for recall | Failed Stability Specifications: product may not meet specification limit for assay test. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide and Puerto Rico |
| Recall initiated | 20150817 |
| Recall number | D-1814-2015 |
| Category | drug |
| Country | Canada |
$29/mo
Try RecallGuard →